CDKN2A is also known as P14ARF. Zhang et al. indicated that up-regulated P14ARF could promote ferroptosis in breast cancer cells by restraining nuclear factor erythroid 2-related factor 2 (NRF2)-mediated transcription of SLC7A11. This evidence concerns the gene NFE2L2 and breast carcinoma.